UBS O'Connor’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-54,176
Closed -$609K – 537
2023
Q3
$609K Hold
54,176
– – 0.01% 383
2023
Q2
$545K Buy
54,176
+12,176
+29% +$113K 0.01% 438
2023
Q1
$395K Buy
42,000
+2,000
+5% +$23.6K 0.01% 479
2022
Q4
$489K Buy
+40,000
New +$499K 0.01% 622
2021
Q1
– Sell
-35,000
Closed -$1.07M – 836
2020
Q4
$1.07M Buy
+35,000
New +$1.07M 0.02% 412
2020
Q1
– Sell
-150,000
Closed -$4.42M – 353
2019
Q4
$4.42M Sell
150,000
-320,000
-68% -$8.7M 0.13% 139
2019
Q3
$12.5M Buy
+470,000
New +$14.1M 0.35% 63

Other funds holding ELAN

UBS O'Connor's ELAN Position: Q4 2023 in Review

UBS O'Connor sold out of Elanco Animal Health (ELAN) in Q4 2023, closing a stake of 54,176 shares — an estimated $609K sold.

UBS O'Connor first reported a position in ELAN in Q3 2019 and held it in 7 quarters. The position peaked at $12.5M in Q3 2019. 355 funds tracked by Wall St. Rank hold ELAN as of Q4 2023.

  • UBS O'Connor reported no remaining Elanco Animal Health position as of Q4 2023 after selling out during the quarter.
  • UBS O'Connor sold 54,176 Elanco Animal Health shares in Q4 2023, an estimated $609K.
  • UBS O'Connor first reported a position in Elanco Animal Health in Q3 2019 and held it in 7 quarters.
  • UBS O'Connor's Elanco Animal Health position peaked at $12.5M in Q3 2019.
  • 355 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.